ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2017
The role of endoscopic therapy in obesity management: intragastric balloons and aspiration therapy.
Review in Diabetes, metabolic syndrome and obesity : targets and therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03598920 (Study of Safety and Efficacy Assessment of Aspiration Therapy for Morbidly Obese Adolescents), which is not on this map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Study of Safety and Efficacy Assessment of Aspiration Therapy for Morbidly Obese Adolescents
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.
- Intragastric Balloon Versus Endoscopic Sleeve Gastroplasty for the Treatment of Obesity: a Systematic Review and Meta-analysis.Obesity surgery · 2020Pooled it
- Safety and short-term effectiveness of endoscopic sleeve gastroplasty using overstitch: preliminary report from a multicenter study.Surgical endoscopy · 2020Trial
- Small Bowel Obstruction Following Dislodgement of an Intragastric Balloon: A Case Report.Cureus · 2024Article
- Overview on the endoscopic treatment for obesity: A review.World journal of gastroenterology · 2023Review
- Bariatric surgery, gastrointestinal hormones, and the microbiome: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022.Obesity pillars · 2022Article
- Perceived barriers and facilitators to healthy eating and physical activity in endoscopic bariatric patients: a qualitative study.Eating and weight disorders : EWD · 2022Article
- Adverse Events and Complications with Intragastric Balloons: a Narrative Review (with Video).Obesity surgery · 2021Review
- Endobariatrics and Metabolic Endoscopy: Can We Solve the Obesity Epidemic with Our Scope?Current gastroenterology reports · 2020Review
- Hidden dangers and updated labels on gastric balloons.Clinical case reports · 2020Article
- From the Knife to the Endoscope-a History of Bariatric Surgery.Current obesity reports · 2020Review
- Biomaterials in Gastroenterology: A Critical Overview.Medicina (Kaunas, Lithuania) · 2019Review
- New Era: Endoscopic treatment options in obesity-a paradigm shift.World journal of gastroenterology · 2019Review
- Conversion of AspireAssist System® to Sleeve Gastrectomy: Technical Video Description.Obesity surgery · 2019Article
- Standardization of Bariatric Metabolic Procedures: World Consensus Meeting Statement.Obesity surgery · 2019Article
- Exclusively endoscopic approach to treating gastric perforation caused by an intragastric balloon: case series and literature review.Endoscopy international open · 2018Article
- Gastric Ulceration and Bleeding with Hemodynamic Instability Caused by an Intragastric Balloon for Weight Loss.Clinical endoscopy · 2018Article
- Displacement of the Intragastric Balloon from the Fundus to the Antrum Results in Enhanced Weight Loss.Obesity surgery · 2018Article
- Devices and Endoscopic Bariatric Therapies for Obesity.Current obesity reports · 2018Review
- Laparoscopic management of a small bowel obstruction secondary to Elipse intragastric balloon migration: A case report.International journal of surgery case reports · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Weight management is increasingly incorporating endoscopic bariatric therapy (EBT). As the global burden of obesity and its comorbidities has increased, it is evident that novel therapeutic approaches will be necessary to address the obesity epidemic. EBTs offer greater efficacy than diet and lifestyle modification and lower invasiveness than bariatric surgery. The US Food and Drug Administration has approved two intragastric balloons and aspiration therapy for the treatment of obesity: Apollo Orbera is indicated for the treatment of Class I and Class II obesity, Re Shape Integrated Dual Balloon system is indicated for the same range with a comorbidity, and Aspire Bariatrics AspireAssist is approved for patients with a body mass index of 35-55 kg/m
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.